Abstract:Cutaneous malignant melanoma, commonly known as melanoma skin cancer, is a highly malignant and invasive solid tumor originating from skin melanocytes. [ 1 , 2 ] Recently, the global incidence of malignant melanoma has been escalating. According to GLOBOCAN's statistical report [ 3 ] in 2020, there were over 320,000 new cases and approximately 60,000 deaths were cataloged worldwide. This escalating prevalence underscores the urgent need to enhance melanoma diagnosis, improve treatment modalities, and develop early detection techniques to better patient outcomes. [ 4 ] Amidst this backdrop, the scientific community has been exploring alternative pathophysiological pathways that could offer new preventive and therapeutic strategies. Over the past 2 decades, there has been a significant increase in research investigating the interactions between human diseases and microbial populations. [ 5 ] Gut microbiota (GM) has emerged as a critical environmental factor influencing both human metabolism and various pathologies, including melanoma skin cancer. This link is indicative of what is termed as the This association is part of what is known as the gut-skin axis, which potentially plays a crucial role in regulating disease onset and progression, particularly in skin cancer. [ 6 ] In recent clinical trials, such as a multicenter, biomarker-stratified, randomized placebo-controlled phase I trial. In a multicenter, biomarker-stratified randomized placebo-controlled phase I trial, [ 7 ] GM has shown promise in enhancing responses to immune checkpoint blockade therapies. A recent exploration revealed unique patterns in microbial species level genome bins and pathways correlating with patient progression free survival over 12 months in contrast with those with <12 months progression free survival among 175 patients undergoing immune checkpoint blockade treatment for advanced melanoma, suggesting a complex interplay between GM and melanoma progression. [ 8 ] However, the exact causal mechanisms linking GM to melanoma skin cancer, along with the underlying mechanisms, remain uncertain.

On the Connection Between Planets, Dark Matter and Cancer

Planetary dependence of melanoma

Planetary relationships to birth (imputed conception) rates in humans: A signature of cosmic origin?

Causal relationship between 150 skin microbiomes and prostate cancer: insights from bidirectional mendelian randomization and meta-analysis

Does sex matter? Temporal analyses of melanoma trends among men and women suggest etiologic heterogeneity

A two-step, two-sample Mendelian randomization analysis investigating the interplay between gut microbiota, immune cells, and melanoma skin cancer

Cutaneous malignant melanoma incidence is strongly associated with European depigmented skin type regardless of ambient ultraviolet radiation levels: evidence from Worldwide population-based data

Comment on "Excluding Primordial Black Holes as Dark Matter Based on Solar System Ephemeris"

Contribution of Human Hair in Solar UV Transmission in Skin: Implications for Melanoma Development

Dark matter effects explanation with the torsion in the Minkowski space

Dark Matter Candidates and Searches

Exploring the Complex and Multifaceted Interplay between Melanoma Cells and the Tumor Microenvironment

Radiation Exposure from the Dark

Optimal Celestial Bodies for Dark Matter Detection

Relativistic effects and dark matter in the Solar system from observations of planets and spacecraft

Breast cancer: Occluded role of mitochondria N-acetylserotonin/melatonin ratio in co-ordinating pathophysiology

Dark Matter reconstruction from stellar orbits in the Galactic Centre

Signals for invisible matter from solar-terrestrial observations

Dark Matter Microhalos From Simplified Models

On the anti-correlation between pericentric distance and inner dark matter density of Milky Way's dwarf spheroidal galaxies